636 results on '"Desideri I."'
Search Results
102. PV-0256 European survey on electronic patientreported outcomes by the EORTC young Radiation Oncology Group
103. EP-1653 Evaluation of Italian Radiotherapy research: preliminary analysis
104. OC-0276 Stereotactic radiosurgery plus immunotherapy or targeted therapy for brain metastases from NSCLC
105. PO-0731 Transition from anatomical to geometric expansion modality for high-risk CTV in oropharyngeal cancer
106. Single-Fraction Radiotherapy (SFRT) For Bone Metastases: Patient Selection And Perspectives
107. Single-Fraction Radiotherapy (SFRT) For Bone Metastases: Patient Selection And Perspectives
108. SIOG2021-0157 - Nivolumab in elderly patients with recurrent/metastatic head and neck squamous cell carcinoma: efficacy and safety data from a monocentric experience
109. OD40 - A semi-automatic planning technique for whole breast irradiation with tangential IMRT fields
110. P091 - Concomitant immuno-radiotherapy in metastatic renal cell carcinoma: multicenter analysis
111. WHICH TREATMENT APPROACH FOR ELDERLY PEOPLE WITH SQUAMOUS CELL CARCINOMA OF THE HEAD AND NECK? A NATIONAL SURVEY ON BEHALF OF THE ITALIAN ASSOCIATION OF RADIATION ONCOLOGY(AIRO) HEAD AND NECK STUDY GROUP
112. RADIOTHERAPY, IMMUNOTHERAPIES AND TARGETED THERAPIES IN ELDERLY PATIENTS: A SYSTEMATIC LITERATURE REVIEW
113. Impact of infectious diseases consultation as a part of an antifungal stewardship programme on candidemia outcome in an Italian tertiary-care, University hospital
114. PO-148 Management of bio-radiation dermatitis in HNSCC: emphasizing the role of calcium alginate dressings
115. PO-09 Clinical outcome of stereotactic body radiotherapy for lung-only oligometastatic HNSCC
116. Abstract P3-12-07: Conservative breast reconstruction: Outcomes of 146 consecutive cases of prepectoral, subcutaneous implant-based breast reconstruction in a single-Institution series
117. Abstract P3-12-09: Dosimetric analysis of the pattern of local recurrence in breast cancer patients undergoing breast reconstruction and post-mastectomy radiotherapy
118. Abstract P4-16-04: Oral ibandronate for osteopenic breast cancer patients receiving adjuvant aromatase inhibitors: secondary 5-year survival outcomes analysis of the single-center phase 2 BONADIUV trial
119. TomoTherapy treatments of multiple brain lesions: an in-phantom accuracy evaluation
120. Stereotactic radiotherapy in oligoprogressive and oligorecurrent urothelial cancer patients: A retrospective experience.
121. Benefit of ablative versus palliative-only radiotherapy in combination with nivolumab in patients affected by metastatic kidney and lung cancer
122. Treatment patterns in elderly patients with locally advanced head and neck squamous cell carcinoma (LA-HNSCC): Results from an EORTC led survey
123. EP-1448: Robotic SBRT on liver lesions in oligometastatic CRC patients: a single center experience
124. EP-1186: Dosimetric comparison of planning modalities for GammaKnife radiosurgery of brain metastases
125. PO-0743: Assessment of heart substructures delineation in a phase III cardioprotection trial (SAFE2014)
126. Ductal carcinoma in situ treated with breast conservative surgery and radiotherapy: A national multicentre experience
127. EP-1660: Clinical outcome after robotic radiosurgery for the management of intraorbital lesions
128. OC-0160: DCIS treated with breast conservative surgery and radiotherapy: a national multicentre experience
129. EP-1299: Postmastectomy radiation therapy after subcutaneous direct-to-implant breast reconstruction
130. PO-0868: Nivolumab in association with Radiation Therapy in patients with lung and kidney cancer
131. 262 Poster - Cyclin-dependent kinase 4/6 inhibitors palbociclib or ribociclib combined with endocrine therapy and radiation therapy for patients with metastatic breast cancer
132. 219 Poster - Use of an alfa-lipoic, Methylsulfonylmethane, Boswellia serrata and Bromelain dietary supplement for Aromatase Inhibitors-related Arthralgia Management (AIA): A prospective phase II trial (NCT04161833)
133. 125 Poster - Quality of life improvement and pain reduction in implant-based breast reconstruction by means of selective pectoralis major muscle denervation
134. 13 Oral - Safety of pre-pectoral breast reconstruction followed by post mastectomy radiotherapy
135. Abstract P6-09-07: Triple negative apocrine carcinomas as a distinct subtype of triple negative breast cancer: A case-control study
136. First-line bevacizumab in combination with weekly paclitaxel for metastatic breast cancer: efficacy and safety results from a routine oncology practice analysis
137. Efficacy and safety of everolimus and exemestane for metastatic breast cancer patients: a real-life experience of three Oncology Departments
138. EP-1350: Stereotactic re-irradiation for prostate cancer recurrence after upfront surgery and radiotherapy
139. EP-1351: Stereotactic radiotherapy in recurrent prostate cancer previously treated by radical irradiation
140. EP-1087: Real-world Cetuximab toxicity in curative and recurrent/metastatic setting in HNSCC patients
141. PO-0964: Biomarkers in wound drainage fluids affect response to radiations of head and neck cancer cells
142. EP-1352: Single-fraction stereotactic body radiotherapy for nodal oligorecurrent prostate cancer
143. PO-0624: Gammaknife Radiosurgery in patients receiving anticancer immunotherapy: efficacy and safety
144. EP-1127: Dose to hippocampus in brain metastases radiosurgery: need for an hippocampal sparing approach
145. Impact of molecular subtypes classification concordance between preoperative core needle biopsy and surgical specimen on early breast cancer management: Single-institution experience and review of published literature
146. 215P - Safety of hypofractionated whole breast irradiation after conservative surgery for patients aged less than 60 years: A multi-center comparative study
147. 214P - Pre-specified interim analysis of the SAFE trial (NCT2236806): A 4-arm randomized, double-blind, controlled study evaluating the efficacy and safety of cardiotoxicity prevention in non-metastatic breast cancer patients treated with anthracyclines with or without trastuzumab
148. PO-148: Hypofractionated radiotherapy for head and neck cancer patients unfit for standard treatment
149. Abstract P1-10-04: Accelerated partial breast irradiation versus whole breast irradiation: Health-related quality of life analysis from a phase 3 trial
150. Abstract P2-09-12: A single-blind, randomized, placebo-controlled phase II study to evaluate the impact of oral ibandronate on bone mineral density in osteopenic breast cancer patients receiving adjuvant aromatase inhibitors: Final results of the single-center BONADIUV trial
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.